Penzberg, Germany

Ildiko Wuensche

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2019-2025

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: The Innovative Contributions of Ildiko Wuensche in Biotherapeutics

Introduction: Ildiko Wuensche is a notable inventor based in Penzberg, Germany, recognized for her significant contributions in the field of biotherapeutics. With two patents to her name, she has made strides in developing innovative treatments that target critical pathways in disease processes.

Latest Patents: Wuensche's latest inventions pertain to bispecific antibodies that are designed to bind to programmed cell death protein 1 (PD1) and T-cell immunoglobulin mucin receptor 3 (TIM3). The innovative aspect of these antibodies lies in their unique composition, which includes a first antigen-binding site targeting PD1 and a second site targeting TIM3. Importantly, the bispecific antibody exhibits a lower binding affinity to TIM3 compared to PD1. This specificity enhances potential therapeutic applications aimed at modulating immune responses. Additionally, her inventions encompass methods for producing these molecules and utilizing them effectively in research and clinical settings.

Career Highlights: Throughout her career, Wuensche has been associated with Hoffmann-La Roche Inc., a leading company in healthcare. Her work focuses on advancing antibody technologies that may lead to groundbreaking treatments for various diseases, particularly in oncology and immunology.

Collaborations: Ildiko Wuensche collaborates with other talented professionals in her field, including Laura Codarri-Deak and Georg Fertig. These partnerships exemplify the collaborative spirit in scientific research, where sharing knowledge and expertise is essential for driving innovation.

Conclusion: Ildiko Wuensche's work, especially in the realm of bispecific antibodies, underscores her pivotal role as an inventor in the biopharmaceutical industry. Her contributions not only highlight her inventiveness but also open pathways for new therapeutic strategies that could significantly impact patient care and treatment efficacy. With ongoing collaboration and innovation, Wuensche continues to pave the way for advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…